< Back to previous page
Researcher
Wim Wuyts
- Disciplines:Respiratory medicine
Affiliations
- Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE) (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 10
- Elucidating the Active Role of Traction bronchiectasis and Honeycombing in IPF’s persistent fibrogenesis (EARTH-IPF)From1 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Genetic risk stratification in familial idiopathic pulmonary fibrosis to refine the multimodal screening program for relativesFrom13 Jul 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Co-designing a Core Outcome Set for and with patients with Idiopathic Pulmonary Fibrosis (COCOS-IPF)From1 Jun 2022 → TodayFunding: FWO research project (including WEAVE projects)
- Implementation of a multimodal screening program for interstitial lung disease in rheumatoid arthritis patientsFrom29 Sep 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Early detection of Pulmonary fibrosis by analysis of breathing soundsFrom21 Jan 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Implementation of a standardized screening program for IPF patients and relatives in FlandersFrom1 Jan 2021 → TodayFunding: FWO Applied Biomedical Research (TBM)
- A study on the loss of small airways and epithelial cell changes in chronic lung diseasesFrom15 Oct 2019 → TodayFunding: FWO fellowships
- Small airway homeostasis, the Achilles heel of the lung driving chronic lung disease?From1 Oct 2019 → TodayFunding: IOF - technology concept exploration, BOF - projects
- Rethinking IPF care: charting the course to person-centred integrated care for idiopathic pulmonary fibrosis together with patients and healthcare professionalsFrom14 Feb 2018 → 23 Mar 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
- A multidisciplinary approach for a better diagnosis and understanding of idiopathic pulmonary fibrosis.From1 Sep 2009 → 30 Sep 2009Funding: BOF - Bilateral scientific cooperation
Publications
161 - 170 of 232
- First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value(2016)
Authors: Wim Wuyts
Pages: 739 - 743 - Daily Home Spirometry: A New Milestone in the Field of Pulmonary Fibrosis(2016)
Authors: Wim Wuyts, Jonas Yserbyt, Geert Verleden
Pages: 1033 - 1034 - Anti-acid treatment in patients with IPF: interpret results from post-hoc, subgroup, and exploratory analyses with great caution - Authors' reply(2016)
Authors: Wim Wuyts
Pages: e48 - Gastro-oesophageal reflux and idiopathic pulmonary fibrosis: in search of evidence(2016)
Authors: Wim Wuyts
Pages: 623 - 625 - European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity(2016)
Authors: Wim Wuyts
Pages: 283 - 284 - Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial(2016)
Authors: Wim Wuyts
Pages: 445 - 453 - Medical Therapy in Idiopathic Pulmonary Fibrosis(2016)
Authors: Wim Wuyts
Pages: 368 - 377 - Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis(2016)
Authors: Wim Wuyts
Pages: 381 - 389 - symptom management: dyspnoea and cough(2016)
Authors: Wim Wuyts
Pages: 218 - 230Number of pages: 12 - European IPF Patient Charter: unmet needs and a call to action for healthcare policymakers(2016)
Authors: Wim Wuyts
Pages: 597 - 606